| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,847 | 4,345 | 6,770 | 34,984 | 122,647 |
| Cost of Revenue
|
-3,202 | -2,961 | -6,920 | -19,428 | -51,993 |
|
Gross Profit
|
645 | 1,384 | -150 | 15,556 | 70,654 |
| Selling, General and Administrative Expenses
|
-16,200 | -19,324 | -37,885 | -33,442 | -34,385 |
|
Research and Development Expenses
|
-6 | -107 | -594 | -1,402 | -652 |
| Other Income/Expense, Operating
|
0 | -- | 0 | -1,932 | -12,022 |
|
Operating Income/Expenses
|
-16,206 | -19,431 | -38,479 | -36,776 | -47,059 |
|
Total Operating Profit/Loss
|
-15,561 | -18,047 | -38,629 | -21,220 | 23,595 |
| Total Net Finance Income/Expense
|
-7,249 | -6,933 | -3,350 | -1,188 | -611 |
| Net Investment Income
|
-285 | 46 | 0 | 0 | -76 |
| Irregular Income/Expenses
|
1,103 | -597 | -333 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
136 | 2,144 | -18 | 10 | 0 |
|
Non-Operating Income/Expenses, Total
|
-6,295 | -5,340 | -3,701 | -1,178 | -687 |
|
Pretax Income
|
-21,856 | -23,387 | -42,330 | -22,398 | 22,908 |
|
Provision for Income Tax
|
-607 | 0 | -7,195 | 6,018 | -4,445 |
|
Net Income from Continuing Operations
|
-22,463 | -23,387 | -49,525 | -16,380 | 18,463 |
|
Discontinued Operations
|
0 | 8,644 | -3,839 | -402 | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-22,463 | -14,743 | -53,364 | -16,782 | 18,463 |
|
Net Income after Non-Controlling/Minority Interests
|
-22,463 | -14,743 | -53,364 | -16,782 | 18,463 |
|
Net Income Available to Common Stockholders
|
-22,463 | -14,743 | -53,364 | -16,782 | 18,463 |
|
Dilution to Earnings
|
-- | -- | -- | 0 | 632 |
|
Diluted Net Income Available to Common Stockholders
|
-22,463 | -14,743 | -53,364 | -16,782 | 19,095 |
| Basic EPS
|
-2.06 | -1.74 | -26.68 | -9.80 | 11.70 |
| Diluted EPS
|
-2.06 | -1.74 | -26.68 | -9.80 | 10.20 |
|
Basic Weighted Average Shares Outstanding
|
13,154.5000 | 8,489 | 2,000 | 1,720.7000 | 1,584.5000 |
|
Diluted Weighted Average Shares Outstanding
|
13,154.5000 | 8,489 | 2,000 | 1,720.7000 | 1,865.1000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-14,607 | -16,454 | -38,980 | -21,210 | 23,519 |
|
EBITDA
|
-10,664 | -11,395 | -32,336 | -14,739 | 28,580 |
|
Normalized EBITDA
|
-5,149 | -6,914 | -17,897 | -11,416 | 38,622 |
12/31/2022 - 4/4/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade